Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2639 (LINC02639)

Target
LINC02639
Molecular classification
Other, long intergenic non-coding RNA (lincRNA) family
01

Overview

Long intergenic non-protein coding RNA 2639 (LINC02639) is a member of the lincRNA class, which are RNA transcripts longer than 200 nucleotides and do not overlap with protein-coding genes. lincRNAs are notable for their roles in regulating gene expression, remodeling chromatin, stabilizing RNA, and modulating transcription, often with high tissue specificity. While certain lincRNAs have established significance in cellular physiology and disease, most, including LINC02639, have not been functionally characterized in detail. Their primary mechanism often involves sequence-dependent and sequence-independent regulation of adjacent or distal genes, but no disease association, therapeutic relevance, or actionable pharmacology is currently defined for LINC02639. It is classified as a long intergenic non-coding RNA and not as a classical druggable target. As of current knowledge, no drugs, biomarkers, or direct disease associations have been established for LINC02639. The gene’s potential regulatory activities are inferred from the broader lincRNA family, which is known for diverse functions in gene expression and chromatin biology. The designation and abbreviation (LINC02639) are accurate and not misspelled.

Other names
LINC02639
02

Mechanism of action

Not applicable; mechanisms for drug targeting are not described for this molecule

03

Biological functions

Gene expression regulationChromatin remodelingRNA stabilizationTranscription regulation (including enhancer-like activity)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2639 (LINC02639).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2639 (LINC02639).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call